Health Canada
- Status: approved
🇨🇦 fIPV at 6-14-22 weeks of age, RotaTeq in Canada
fIPV at 6-14-22 weeks of age, RotaTeq (fIPV at 6-14-22 weeks of age, RotaTeq) regulatory status in Canada.
Marketing authorisation
fIPV at 6-14-22 weeks of age, RotaTeq in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Frequently asked questions
Is fIPV at 6-14-22 weeks of age, RotaTeq approved in Canada?
Yes. Health Canada has authorised it.
Who is the marketing authorisation holder for fIPV at 6-14-22 weeks of age, RotaTeq in Canada?
Centers for Disease Control and Prevention is the originator. The local marketing authorisation holder may differ — check the official source linked above.